Literature DB >> 19889782

Protective memory responses are modulated by priming events prior to challenge.

John A Rutigliano1, Melissa Y Morris, Wen Yue, Rachael Keating, Richard J Webby, Paul G Thomas, Peter C Doherty.   

Abstract

Human infections with highly pathogenic H5N1 avian influenza A viruses in the last decade have legitimized fears of a long-predicted pandemic. We thus investigated the response to secondary infections with an engineered, but still highly virulent, H5N1 influenza A virus in the C57BL/6 mouse model. Mice primed with the H1N1 A/Puerto Rico/8/34 (PR8) virus were partially protected from lethality following respiratory infection with the modified H5N1 virus A/Vietnam/1203/04 (DeltaVn1203). In contrast, those that had been comparably exposed to the HKx31 (H3N2) virus succumbed to the DeltaVn1203 challenge, despite similarities in viral replication, weight loss, and secondary CD8(+)-T-cell response characteristics. All three viruses share the internal genes of PR8 that are known to stimulate protective CD8(+)-T-cell-mediated immunity. This differential survival of PR8- and HKx31-primed mice was also apparent for antibody-deficient mice challenged with the DeltaVn1203 virus. The relative protection afforded by PR8 priming was abrogated in tumor necrosis factor-deficient (TNF(-/-)) mice, although lung fluids from the B6 HKx31-primed mice contained more TNF early after challenge. These data demonstrate that the nature of the primary infection can influence pathological outcomes following virulent influenza virus challenge, although the effect is not clearly correlated with classical measures of CD8(+)-T-cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889782      PMCID: PMC2798378          DOI: 10.1128/JVI.01535-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Receptor binding properties of human and animal H1 influenza virus isolates.

Authors:  G N Rogers; B L D'Souza
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

2.  Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

Authors:  M N Matrosovich; A S Gambaryan; S Teneberg; V E Piskarev; S S Yamnikova; D K Lvov; J S Robertson; K A Karlsson
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

3.  Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes.

Authors:  A Vitiello; L Yuan; R W Chesnut; J Sidney; S Southwood; P Farness; M R Jackson; P A Peterson; A Sette
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

4.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.

Authors:  E C Claas; A D Osterhaus; R van Beek; J C De Jong; G F Rimmelzwaan; D A Senne; S Krauss; K F Shortridge; R G Webster
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

5.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

Authors:  K Subbarao; A Klimov; J Katz; H Regnery; W Lim; H Hall; M Perdue; D Swayne; C Bender; J Huang; M Hemphill; T Rowe; M Shaw; X Xu; K Fukuda; N Cox
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

6.  A pandemic warning?

Authors:  J C de Jong; E C Claas; A D Osterhaus; R G Webster; W L Lim
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

7.  Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached.

Authors:  Y Suzuki; Y Nagao; H Kato; M Matsumoto; K Nerome; K Nakajima; E Nobusawa
Journal:  J Biol Chem       Date:  1986-12-25       Impact factor: 5.157

8.  Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.

Authors:  S Hou; P C Doherty; M Zijlstra; R Jaenisch; J M Katz
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

9.  Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates.

Authors:  R J Connor; Y Kawaoka; R G Webster; J C Paulson
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

10.  Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice.

Authors:  M B Graham; T J Braciale
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

View more
  11 in total

1.  A comprehensive collection of systems biology data characterizing the host response to viral infection.

Authors:  Brian D Aevermann; Brett E Pickett; Sanjeev Kumar; Edward B Klem; Sudhakar Agnihothram; Peter S Askovich; Armand Bankhead; Meagen Bolles; Victoria Carter; Jean Chang; Therese R W Clauss; Pradyot Dash; Alan H Diercks; Amie J Eisfeld; Amy Ellis; Shufang Fan; Martin T Ferris; Lisa E Gralinski; Richard R Green; Marina A Gritsenko; Masato Hatta; Robert A Heegel; Jon M Jacobs; Sophia Jeng; Laurence Josset; Shari M Kaiser; Sara Kelly; G Lynn Law; Chengjun Li; Jiangning Li; Casey Long; Maria L Luna; Melissa Matzke; Jason McDermott; Vineet Menachery; Thomas O Metz; Hugh Mitchell; Matthew E Monroe; Garnet Navarro; Gabriele Neumann; Rebecca L Podyminogin; Samuel O Purvine; Carrie M Rosenberger; Catherine J Sanders; Athena A Schepmoes; Anil K Shukla; Amy Sims; Pavel Sova; Vincent C Tam; Nicolas Tchitchek; Paul G Thomas; Susan C Tilton; Allison Totura; Jing Wang; Bobbie-Jo Webb-Robertson; Ji Wen; Jeffrey M Weiss; Feng Yang; Boyd Yount; Qibin Zhang; Shannon McWeeney; Richard D Smith; Katrina M Waters; Yoshihiro Kawaoka; Ralph Baric; Alan Aderem; Michael G Katze; Richard H Scheuermann
Journal:  Sci Data       Date:  2014-10-14       Impact factor: 6.444

2.  Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells.

Authors:  John A Rutigliano; Shalini Sharma; Melissa Y Morris; Thomas H Oguin; Jennifer L McClaren; Peter C Doherty; Paul G Thomas
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 3.  Immunity to seasonal and pandemic influenza A viruses.

Authors:  Sophie A Valkenburg; John A Rutigliano; Ali H Ellebedy; Peter C Doherty; Paul G Thomas; Katherine Kedzierska
Journal:  Microbes Infect       Date:  2011-02-02       Impact factor: 2.700

4.  Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.

Authors:  Shabnam Alam; Andrea J Sant
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

5.  Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection.

Authors:  Ellyse M Cipolla; Molin Yue; Kara L Nickolich; Brydie R Huckestein; Danielle Antos; Wei Chen; John F Alcorn
Journal:  J Immunol       Date:  2022-08-01       Impact factor: 5.426

6.  GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates.

Authors:  Peter T Loudon; Eric J Yager; Debbie T Lynch; Amithi Narendran; Cristy Stagnar; Anthony M Franchini; James T Fuller; Phil A White; Julia Nyuandi; Clayton A Wiley; Michael Murphey-Corb; Deborah H Fuller
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

7.  Lipid composition of viral envelope of three strains of influenza virus - not all viruses are created equal.

Authors:  Pavlina T Ivanova; David S Myers; Stephen B Milne; Jennifer L McClaren; Paul G Thomas; H Alex Brown
Journal:  ACS Infect Dis       Date:  2015-06-24       Impact factor: 5.084

Review 8.  Avian influenza A H5N1 virus: a continuous threat to humans.

Authors:  Kelvin Kw To; Kenneth Hl Ng; Tak-Lun Que; Jacky Mc Chan; Kay-Yan Tsang; Alan Kl Tsang; Honglin Chen; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-09-19       Impact factor: 7.163

9.  Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses.

Authors:  Peter S Askovich; Catherine J Sanders; Carrie M Rosenberger; Alan H Diercks; Pradyot Dash; Garnet Navarro; Peter Vogel; Peter C Doherty; Paul G Thomas; Alan Aderem
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

Authors:  Rachael Keating; Tomer Hertz; Marie Wehenkel; Tarsha L Harris; Benjamin A Edwards; Jennifer L McClaren; Scott A Brown; Sherri Surman; Zachary S Wilson; Philip Bradley; Julia Hurwitz; Hongbo Chi; Peter C Doherty; Paul G Thomas; Maureen A McGargill
Journal:  Nat Immunol       Date:  2013-10-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.